Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope

Journal of Experimental Medicine

Volumn 208, Issue 7, 2011, Pages 1501-1510

  Daniel, Carolin ^a,d   Weigmann, Benno ^c   Bronson, Roderick ^d   von Boehmer, Harald ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INSULIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; EPITOPES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; INSULIN; INSULIN ANTIBODIES; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PANCREAS; T-LYMPHOCYTES, REGULATORY; VACCINATION; VACCINES;

EID: 79960369940     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20110574     Document Type: Article

References (54)

1. Alleva, D.G., P.D. Crowe, L. Jin, W.W. Kwok, N. Ling, M. Gottschalk, P.J. Conlon, P.A. Gottlieb, A.L. Putnam, and A. Gaur. 2001. A diseaseassociated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J. Clin. Invest. 107:173-180.
2. Alleva, D.G., A. Gaur, L. Jin, D. Wegmann, P.A. Gottlieb, A. Pahuja, E.B. Johnson, T. Motheral, A. Putnam, P.D. Crowe, et al. 2002. Immunological characterization and therapeutic activity of an alteredpeptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes. 51:2126-2134.
3. Apostolou, I., and H. von Boehmer. 2004. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199:1401-1408.
4. Aspord, C., and C. Thivolet. 2002. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice. Clin. Exp. Immunol. 130:204-211.
5. Babaya, N., E. Liu, D. Miao, M. Li, L. Yu, and G.S. Eisenbarth. 2009. Murine high specificity/sensitivity competitive europium insulin autoantibody assay. Diabetes Technol. Ther. 11:227-233.
6. Bergerot, I., C. Ploix, J. Petersen, V. Moulin, C. Rask, N. Fabien, M. Lindblad, A. Mayer, C. Czerkinsky, J. Holmgren, and C. Thivolet. 1997. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 94:4610-4614.
7. Chen, W., I. Bergerot, J.F. Elliott, L.C. Harrison, N. Abiru, G.S. Eisenbarth, and T.L. Delovitch. 2001. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes. J. Immunol. 167:4926-4935.
8. Daniel, D., and D.R. Wegmann. 1996. Intranasal administration of insulin peptide B: 9-23 protects NOD mice from diabetes. Ann. N. Y. Acad. Sci. 778:371-372.
9. Daniel, C., K. Wennhold, H.J. Kim, and H. von Boehmer. 2010. Enhancement of antigen-specific Treg vaccination in vivo. Proc. Natl. Acad. Sci. USA. 107:16246-16251.
10. Daniel, C., H. Ploegh, and H. von Boehmer. 2011. Antigen-specific induction of regulatory T cells in vivo and in vitro. Methods Mol. Biol. 707:173-185.
11. Fairchild, P.J., R. Wildgoose, E. Atherton, S. Webb, and D.C. Wraith. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5:1151-1158.
12. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329-341.
13. Garcia, K.C., L. Teyton, and I.A. Wilson. 1999. Structural basis of T cell recognition. Annu. Rev. Immunol. 17:369-397.
14. Gottschalk, R.A., E. Corse, and J.P. Allison. 2010. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207:1701-1711.
15. Hahn, M., M.J. Nicholson, J. Pyrdol, and K.W. Wucherpfennig. 2005. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat. Immunol. 6:490-496.
16. Harrison, L.C., M. Dempsey-Collier, D.R. Kramer, and K. Takahashi. 1996. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184:2167-2174.
17. Jaeckel, E., L. Klein, N. Martin-Orozco, and H. von Boehmer. 2003. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase. J. Exp. Med. 197:1635-1644.
18. Jaeckel, E., M.A. Lipes, and H. von Boehmer. 2004. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat. Immunol. 5:1028-1035.
19. Jasinski, J.M., L. Yu, M. Nakayama, M.M. Li, M.A. Lipes, G.S. Eisenbarth, and E. Liu. 2006. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent on RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Diabetes. 55:1978-1984.
20. Josefowicz, S.Z., C.B. Wilson, and A.Y. Rudensky. 2009. Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1. J. Immunol. 182:6648-6652.
21. Klein, L., K. Khazaie, and H. von Boehmer. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA. 100:8886-8891.
22. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M.C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6:1219-1227.
23. Krishnamurthy, B., N.L. Dudek, M.D. McKenzie, A.W. Purcell, A.G. Brooks, S. Gellert, P.G. Colman, L.C. Harrison, A.M. Lew, H.E. Thomas, and T.W. Kay. 2006. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J. Clin. Invest. 116:3258-3265.
24. Lahl, K., C. Loddenkemper, C. Drouin, J. Freyer, J. Arnason, G. Eberl, A. Hamann, H. Wagner, J. Huehn, and T. Sparwasser. 2007. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204:57-63.
25. Lanoue, A., C. Bona, H. von Boehmer, and A. Sarukhan. 1997. Conditions that induce tolerance in mature CD4+ T cells. J. Exp. Med. 185:405-414.
26. Lee, K.H., K.W. Wucherpfennig, and D.C. Wiley. 2001. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat. Immunol. 2:501-507.
27. Li, D.S., Y.H. Yuan, H.J. Tu, Q.L. Liang, and L.J. Dai. 2009. A protocol for islet isolation from mouse pancreas. Nat. Protoc. 4:1649-1652.
28. Liu, G.Y., P.J. Fairchild, R.M. Smith, J.R. Prowle, D. Kioussis, and D.C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 3:407-415.
29. Martinez, N.R., P. Augstein, A.K. Moustakas, G.K. Papadopoulos, S. Gregori, L. Adorini, D.C. Jackson, and L.C. Harrison. 2003. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J. Clin. Invest. 111:1365-1371.
30. Merkenschlager, M., and H. von Boehmer. 2010. PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors. J. Exp. Med. 207:1347-1350.
31. Michel, C., C. Boitard, and J.F. Bach. 1989. Insulin autoantibodies in nonobese diabetic (NOD) mice. Clin. Exp. Immunol. 75:457-460.
32. Nakayama, M., N. Abiru, H. Moriyama, N. Babaya, E. Liu, D. Miao, L. Yu, D.R. Wegmann, J.C. Hutton, J.F. Elliott, and G.S. Eisenbarth. 2005. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature. 435:220-223.
33. Orban, T., K. Farkas, H. Jalahej, J. Kis, A. Treszl, B. Falk, H. Reijonen, J. Wolfsdorf, A. Ricker, J.B. Matthews, et al. 2010. Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy. J. Autoimmun. 34:408-415.
34. Polansky, J.K., K. Kretschmer, J. Freyer, S. Floess, A. Garbe, U. Baron, S. Olek, A. Hamann, H. von Boehmer, and J. Huehn. 2008. DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 38:1654-1663.
35. Pugliese, A., M. Zeller, A. Fernandez Jr., L.J. Zalcberg, R.J. Bartlett, C. Ricordi, M. Pietropaolo, G.S. Eisenbarth, S.T. Bennett, and D.D. Patel. 1997. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTRIDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15:293-297.
36. Reddy, S., N.J. Bibby, and R.B. Elliott. 1988. Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse. Diabetologia. 31:322-328.
37. Rubtsov, Y.P., R.E. Niec, S. Josefowicz, L. Li, J. Darce, D. Mathis, C. Benoist, and A.Y. Rudensky. 2010. Stability of the regulatory T cell lineage in vivo. Science. 329:1667-1671.
38. Sauer, S., L. Bruno, A. Hertweck, D. Finlay, M. Leleu, M. Spivakov, Z.A. Knight, B.S. Cobb, D. Cantrell, E. O'Connor, et al. 2008. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA. 105:7797-7802.
39. Sethi, D.K., D.A. Schubert, A.K. Anders, A. Heroux, D.A. Bonsor, C.P. Thomas, E.J. Sundberg, J. Pyrdol, and K.W. Wucherpfennig. 2011. A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC. J. Exp. Med. 208:91-102.
40. Stadinski, B.D., L. Zhang, F. Crawford, P. Marrack, G.S. Eisenbarth, and J.W. Kappler. 2010. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc. Natl. Acad. Sci. USA. 107:10978-10983.
41. Sundstedt, A., E.J. O'Neill, K.S. Nicolson, and D.C. Wraith. 2003. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol. 170:1240-1248.
42. Suri, A., J.J. Walters, M.L. Gross, and E.R. Unanue. 2005. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity. J. Clin. Invest. 115:2268-2276.
43. Suri, A., M.G. Levisetti, and E.R. Unanue. 2008. Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity? Curr. Opin. Immunol. 20:105-110.
44. Szot, G.L., P. Koudria, and J.A. Bluestone. 2007. Murine pancreatic islet isolation. J. Vis. Exp. 7:255.
45. Tarbell, K.V., S. Yamazaki, K. Olson, P. Toy, and R.M. Steinman. 2004. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199:1467-1477.
46. Tarbell, K.V., L. Petit, X. Zuo, P. Toy, X. Luo, A. Mqadmi, H. Yang, M. Suthanthiran, S. Mojsov, and R.M. Steinman. 2007. Dendritic cellexpanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204:191-201.
47. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell. 85:291-297.
48. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M.K. Gately, and L. Adorini. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817-821.
49. Verginis, P., K.A. McLaughlin, K.W. Wucherpfennig, H. von Boehmer, and I. Apostolou. 2008. Induction of antigen-specific regulatory T cells in wild-type mice: visualization and targets of suppression. Proc. Natl. Acad. Sci. USA. 105:3479-3484.
50. Weigmann, B., H.A. Lehr, G. Yancopoulos, D. Valenzuela, A. Murphy, S. Stevens, J. Schmidt, P.R. Galle, S. Rose-John, and M.F. Neurath. 2008. The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. J. Exp. Med. 205:2099-2110.
51. Wucherpfennig, K.W., and D. Sethi. 2011. T cell receptor recognition of self and foreign antigens in the induction of autoimmunity. Semin. Immunol. 23:84-91.
52. Yu, L., D.T. Robles, N. Abiru, P. Kaur, M. Rewers, K. Kelemen, and G.S. Eisenbarth. 2000. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc. Natl. Acad. Sci. USA. 97:1701-1706.
53. Zhang, Z.J., L. Davidson, G. Eisenbarth, and H.L. Weiner. 1991. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA. 88:10252-10256.
54. Ziegler, A.G., R. Ziegler, P. Vardi, R.A. Jackson, J.S. Soeldner, and G.S. Eisenbarth. 1989. Life-table analysis of progression to diabetes of antiinsulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes. 38:1320-1325.